by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerForm 483sGlaxoSmithKline LLC

GlaxoSmithKline LLC

Form 483FOIA Uncovered

Issued September 25, 2024

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

ObservationsNot available

Issue DateSeptember 25, 2024

StatusNo Warning Letter

Related Inspections0

Establishment Details

Firm: GlaxoSmithKline LLC
Location: N/A
FEI Number: N/A
Issue Date: September 25, 2024
Country: N/A

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

GlaxoSmithKline LLC FDA Form 483, September 25, 2024